These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21877597)

  • 41. Hemoglobin control, ESA resistance, and regular low-dose IV iron therapy: a review of the evidence.
    Singh A
    Semin Dial; 2009; 22(1):64-9. PubMed ID: 19175537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential roles of erythropoietin in the management of anaemia and other complications diabetes.
    Khoshdel A; Carney S; Gillies A; Mourad A; Jones B; Nanra R; Trevillian P
    Diabetes Obes Metab; 2008 Jan; 10(1):1-9. PubMed ID: 17645562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron management in nondialysis-dependent CKD.
    Fishbane S
    Am J Kidney Dis; 2007 Jun; 49(6):736-43. PubMed ID: 17533016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
    Baldus M; Walter H; Thies K; Anders C; Stein M; Hellstern P; Brass H
    Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iron-deficiency anemia secondary to mutations in genes controlling hepcidin.
    Cau M; Melis MA; Congiu R; Galanello R
    Expert Rev Hematol; 2010 Apr; 3(2):205-16. PubMed ID: 21083463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anemia in chronic renal insufficiency].
    Heilmann E
    Fortschr Med; 1975 Dec; 93(34):1718-20. PubMed ID: 1193526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heart and iron deficiency anaemia in rats with renal insufficiency: the role of hepcidin.
    Toblli JE; Cao G; Rivas C; Kulaksiz H
    Nephrology (Carlton); 2008 Oct; 13(7):636-45. PubMed ID: 18808386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of iron deficiency to anemia in chronic renal failure.
    Gupta M; Kannan M; Gupta S; Saxena R
    Indian J Pathol Microbiol; 2003 Oct; 46(4):563-4. PubMed ID: 15025343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overview of anemia associated with chronic renal disease: primary and secondary mechanisms.
    Paganini EP
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):3-8. PubMed ID: 2648518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Issues related to iron replacement in dialyzed patients].
    Kessler M
    Nephrol Ther; 2006 Sep; 2 Suppl 4():S266-73. PubMed ID: 17373269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mediators of anemia in chronic heart failure.
    Le Jemtel TH; Arain S
    Heart Fail Clin; 2010 Jul; 6(3):289-93. PubMed ID: 20630403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogenesis of the anemia of chronic renal failure: the role of erythropoietin.
    Chandra M; McVicar M; Clemons GK
    Adv Pediatr; 1988; 35():361-89. PubMed ID: 3055863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients.
    Tsuchiya K; Saito M; Okano-Sugiyama H; Nihei H; Ando M; Teramura M; Iwamoto YS; Shimada K; Akiba T
    Ren Fail; 2005; 27(1):59-65. PubMed ID: 15717636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of inflammation on nutrition, iron status, and erythropoietin responsiveness in ESRD patients.
    Bistrian BR; Carey LA
    Nephrol Nurs J; 2000 Dec; 27(6):616-22. PubMed ID: 16649343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.
    Larson K
    Nephrol Nurs J; 2008; 35(2):184-93; quiz 194-5. PubMed ID: 18472686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
    Daschner M; Mehls O; Schaefer F
    Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Characteristics of anaemia treatment in children with chronic kidney disease].
    Puretić Z
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():27-32. PubMed ID: 20235352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benefits and risks of iron therapy for chronic anaemias.
    Weiss G; Gordeuk VR
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():36-45. PubMed ID: 16281957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
    Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
    Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Editorial: Anaemia in chronic renal failure.
    Lancet; 1975 Apr; 1(7913):959-60. PubMed ID: 48128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.